LEADER 03583nam  22006735  450 
001 9910437991703321
005 20200704164945.0
010   $a1-283-61260-7
010   $a9786613925053
010   $a3-642-22107-6
024 7 $a10.1007/978-3-642-22107-1
035   $a(CKB)2670000000251538
035   $a(EBL)972246
035   $a(OCoLC)809542582
035   $a(SSID)ssj0000736276
035   $a(PQKBManifestationID)11489624
035   $a(PQKBTitleCode)TC0000736276
035   $a(PQKBWorkID)10767566
035   $a(PQKB)11655129
035   $a(DE-He213)978-3-642-22107-1
035   $a(MiAaPQ)EBC972246
035   $a(PPN)168308932
035   $a(EXLCZ)992670000000251538
100   $a20120831d2013      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAge-related Macular Degeneration /$fedited by Frank G. Holz, Daniel Pauleikhoff, Richard F. Spaide, Alan C. Bird
205   $a2nd ed. 2013.
210  1$aBerlin, Heidelberg :$cSpringer Berlin Heidelberg :$cImprint: Springer,$d2013.
215   $a1 online resource (323 p.)
300   $aDescription based upon print version of record.
311   $a3-642-22106-8 
320   $aIncludes bibliographical references and index.
327   $aPathophysiology: Epidemiology -- Genetics of AMD -- Aging of the Retina and Retinal Pigment Epithelium -- Complement System -- Current Concepts in AMD-Pathogenesis. Clinical Manifestations: Early AMD -- Neovascular AMD -- Geographic Atrophy. Diagnostics: Fluorescein- und ICG-Angiography -- Optical Coherence Tomography -- Microperimetry. Prophylaxis and Therapy: Nutritional Supplementation -- Laser Photocoagulation and Photodynamic Therapy -- Anti-VEGF-Therapy: Basic Information and Substances -- Anti-VEGF-Therapy: Results and Guidelines -- Combination Therapies for the Treatment of AMD -- Treatment Approaches for Dry Atrophy -- Surgical Therapy. Rehabilitation: Reading Ability -- Magnifying Visual Aids.
330   $aAge-related macular degeneration has become the most common cause of blindness. With population ageing AMD will become an ever more prevalent cause of visual loss. Here, an expert panel of experienced clinicians and eminent basic scientists provide an authoritative review on the pathogenesis, epidemiology and risk factors, diagnostic methods, imaging modalities and treatment strategies for age-related macular degeneration. Many excellent photographs and diagrams add to a clear understanding.
606   $aOphthalmology
606   $aGeriatrics
606   $aDiabetes
606   $aOphthalmology$3https://scigraph.springernature.com/ontologies/product-market-codes/H44004
606   $aGeriatrics/Gerontology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33150
606   $aDiabetes$3https://scigraph.springernature.com/ontologies/product-market-codes/H33045
615  0$aOphthalmology.
615  0$aGeriatrics.
615  0$aDiabetes.
615 14$aOphthalmology.
615 24$aGeriatrics/Gerontology.
615 24$aDiabetes.
676   $a618.977735
702   $aHolz$b Frank G$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aPauleikhoff$b Daniel$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aSpaide$b Richard F$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aBird$b Alan C$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910437991703321
996   $aAge-related macular degeneration$92116600
997   $aUNINA